MDT Progresses on Renal Denervation – Analyst Blog

By | October 4, 2012
0 Comment

Leading medical devices player, Medtronic ( MDT ) has progressed with respect to its renal denervation program. The company began a clinical trial with the system in Japan for patients

Read More:
MDT Progresses on Renal Denervation – Analyst Blog

Related posts:

  1. Athenahealth Progresses with FQHCs – Analyst Blog
  2. Exxon Progresses with Hebron – Analyst Blog
  3. Roche Oncology Candidate Progresses – Analyst Blog
  4. Merck’s Alzheimer’s Drug Progresses – Analyst Blog